FDA Formally Rescinds Laboratory-Developed Tests Final Rule
The U.S. Food and Drug Administration (FDA) formally rescinded its final rule regulating laboratory-developed tests as...
Stay informed with expert insights, case studies, and tools to help your lab improve performance and make smarter revenue decisions.
The U.S. Food and Drug Administration (FDA) formally rescinded its final rule regulating laboratory-developed tests as...
The Centers for Medicare & Medicaid Services (CMS) will now allow laboratories to bill the laboratory specimen...
The Centers for Medicare & Medicaid Services (CMS) announced the introduction of the Health Tech Ecosystem initiative...
Humana announced on July 22 that it would accelerate efforts to eliminate its prior authorization requirements.
Clinical Laboratory Improvement Amendments (CLIA) certification is transitioning to a paperless system for receiving...
The Centers for Medicare & Medicaid Services (CMS) is expanding Medicare coverage for genetic testing through the MolDX...
On June 27, the Centers for Medicare & Medicaid Services (CMS) announced a new model for expediting prior authorization...
The national trade association America’s Health Insurance Plans (AHIP) announced on June 23 that major U.S. health...
The U.S. Centers for Medicare & Medicaid Services (CMS) will hold its Clinical Laboratory Fee Schedule (CLFS) Annual...
On May 29, Medicare announced it would expand coverage for genomic sequence analysis panels in the treatment of...
A bill introduced in the U.S. House of Representatives in late March seeks to increase transparency around prior...
On May 20, Sens. Mark Warner (D-Va.) and Roger Marshall, M.D. (R-Kan.) reintroduced the Improving Seniors’ Timely...